ClinicalTrials.gg
TerminatedNCT03422783Updated Jul 17, 2024

Correlation Between NOL Index After Stimulus and Post-operative Opioid, Pain, Pre-operative Phenotype

An interventional study of Standardized tetanic stimulation and Catastrophizing score in Pain, Postoperative, Anesthesia and Catastrophizing, sponsored by Ciusss de L'Est de l'Île de Montréal. Terminated at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-17.

Sponsored by Ciusss de L'Est de l'Île de Montréal · Not applicable, Interventional, and Diagnostic

Why this study was terminated
Stopped in march 2024 because lead investigator left Canada
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS).

Read the detailed description

The NoL index, a nociception monitor using a multiparametric approach, has shown an excellent sensitivity and specificity in detecting noxious stimuli under general anesthesia. This monitor is better than any other parameter in grading nociception under general anesthesia. More recently, it has recently been shown a strong correlation between NoL index response to nociceptive stimulus and the level of opioid analgesia during surgery. No study has evaluated that NoL could predict post-operative pain so far. It has not yet been proven that NoL was correlated with post-operative opioid consumption or with post-operative pain scores.

Some phenotypic factors were previously shown to correlate with post-operative pain and opioid consumption, such as psychological factors and tests, or also assessment of some pre-operative nociceptive thresholds (NT). Pain catastrophizing was proven in several studies to correlate with acute post-operative pain.

So far, no study compared each of these preoperative psychological factors or nociceptif thresholds to the NoL index response to intraoperative standardized pain stimulus in terms of correlation with post-operative opioid requirements and pain scores.

Moreover, there is no study evaluating the pro-inflammatory protein profiles that might likely be correlated to inter-individual differences in NoL response after this standardized nociceptive stimulus under general anesthesia.

This study will assess the level of correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS). It also evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and pre-operative phenotype and post-operative pain biomarkers.

02

Conditions studied

  • Pain, Postoperative
  • Anesthesia
  • Catastrophizing
  • Nociceptive Pain

Keywords

  • Monitoring
  • Biomarker
  • Thoracoscopy
03

In context

Pain, Postoperative

5,227 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's enrollment of 31 is below the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Ciusss de L'Est de l'Île de Montréal is the lead sponsor of 88 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient (Age 18 or older)
  • ASA status I, II or III
  • elective video assisted thoracoscopy under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • history of coronary artery disease
  • serious cardiac arrhythmia (including atrial fibrillation),
  • history of substance abuse,
  • chronic use of psychotropic and/or opioid drugs,
  • use of drugs that act on the autonomic nervous system (including β-blockers),
  • history of psychiatric diseases,
  • allergy to any drug used in the study protocol,
  • refusal of the patient
  • unexpected difficult airway requesting excessive, possibly painful airway manipulations
  • unexpected intraoperative complications requiring strong hemodynamic support (transfusions, vasopressors, inotropes)
  • conversion to thoracotomy
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Included patients

    There is only one arm in this study. Intervention will be electrical forearm stimulus under general anesthesia and the response of NOL index following this stimulus and its correlation with postoperative parameters such as pain and opioid consumption in post anesthesia care unit.

    Device: Standardized tetanic stimulation · Diagnostic Test: Catastrophizing score · Diagnostic Test: Nociceptive threshold · Biological: Biomarkers

Interventions

  • DeviceStandardized tetanic stimulation

    The "intervention" is not a drug, but it is standardized electrical stimulus applied with a muscle relaxation monitor on the forearm of the anesthetized patient. The NoL index is registered in response to this stimulus in an observational manner. Device: Device PMD200TM offering intraoperative NoL Index

  • Diagnostic testCatastrophizing score

    Pre-operative catastrophizing score is correlated with post-operative pain and opioid consumption

  • Diagnostic testNociceptive threshold

    Nociceptive threshold for pressure, heat and electrical stimulation are associated with post-operative pain and will be assessed preoperatively to see if there is correlation between them and the NOL index response to the nociceptive stimulus (see intervention 1)

  • BiologicalBiomarkers

    Some biomarkers of inflammation and endogenous opioids are associated with post-operative pain. Blood samples will be withdrawn at D0 before surgery starts, D1 (H24) and D2 (H48) after surgery to see if they correlate with NOL changes after the stimulus described in intervention 1 above

06

What researchers measure

Primary outcomes

  1. Correlation between NoL index and Hydromorphone consumption H24

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Total hydromorphone consumption (PACU and PCA) 24h after surgery

    Time frame: Day 1 at 24 hours

Secondary outcomes

  1. Pain scores (NRS) in PACU from 0 to 10

    Pain scores from 0 to 10 after surgery, using numerical rating scale in post anesthesiology care unit

    Time frame: Day 0 at hour 2

  2. Correlation between NoL index and Pain scores (NRS from 0 to 10) in PACU

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores after surgery, in post anesthesiology care unit

    Time frame: Day 0 at hour 2

  3. Pain scores (NRS from 0 to 10) at H24 at rest

    Pain scores (NRS from 0 to 10) at H24 at rest

    Time frame: Day 1 at 24 hours

  4. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 at rest

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H24 at rest

    Time frame: Day 1 at 24 hours

  5. Pain scores (NRS) at H24 while coughing from 0 to 10

    Pain scores (NRS) at H24 while coughing from 0 to 10

    Time frame: Day 1 at 24 hours

  6. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 while coughing

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H24 while coughing

    Time frame: Day 1 at 24 hours

  7. Pain scores (NRS) at H48 at rest from 0 to 10

    Pain scores (NRS) at H48 at rest from 0 to 10

    Time frame: Day 2 at 48 hours

  8. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H48 at rest

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H48 at rest

    Time frame: Day 2 at 48 hours

  9. Pain scores (NRS) at H48 while coughing from 0 to 10

    Pain scores (NRS) at H48 while coughing from 0 to 10

    Time frame: Day 2 at 48 hours

  10. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H48 while coughing

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H48 while coughing

    Time frame: Day 2 at 48 hours

  11. total hydromorphone consumption (mg) in PACU

    general anesthesia and total hydromorphone consumption (mg) in PACU

    Time frame: Day 0 at 2 hours

  12. Correlation between NoL index and total hydromorphone consumption (mg) in PACU

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and total hydromorphone consumption (mg) in PACU

    Time frame: Day 0 at 2 hours

  13. Total hydromorphone consumption (mg) at H48

    Total hydromorphone consumption (mg) at H48

    Time frame: Day 2 at 48 hours

  14. Correlation between NoL index and total hydromorphone consumption (mg) at H48

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and total hydromorphone consumption (mg) at H48

    Time frame: Day 2 at 48 hours

  15. Pain catastrophizing scale from 0 to 50 (fully validated and published questionnaire)

    Pain catastrophizing scale from 0 to 50

    Time frame: Pre-operative, 2 hours prior to surgery

  16. Correlation between Pain catastrophizing scale from 0 to 50 and Total (hydromorphone consumption at day 1 24 hours)

    Correlation between Pain catastrophizing scale and Total hydromorphone

    Time frame: Day 1 at 24 hours

  17. Correlation between Pain catastrophizing scale from 0 to 50 and NoL index

    Correlation between pre-operative Pain catastrophizing scale and NoL index absolute values after electrical stimulus under general anesthesia

    Time frame: Day 0

  18. State-Trait anxiety Inventory from 0 to 80 (fully validated and published questionnaire)

    State-Trait anxiety Inventory from 0 to 80

    Time frame: Day 0

  19. Correlation between State-Trait anxiety Inventory questionnaire from 0 to 80 and NoL index

    Correlation between pre-operative State-Trait anxiety Inventory and NoL index absolute values after electrical stimulus under general anesthesia

    Time frame: Day 0

  20. Correlation between State-Trait anxiety Inventory from 0 to 80 and Total hydromorphone consumption at H24

    Correlation between State-Trait anxiety Inventory and Total hydromorphone consumption at H24

    Time frame: Day 1 24 hours

  21. mechanic pain threshold

    mechanic pain threshold using electronic Von Frey

    Time frame: Pre-operative, 2 hours prior to surgery

  22. thermal pain threshold

    thermal pain threshold using Qsense device

    Time frame: Pre-operative, 2 hours prior to surgery

  23. electrical pain threshold

    electrical pain threshold using Pain Matcher device

    Time frame: Pre-operative, 2 hours prior to surgery

  24. Biomarkers level Pre-op

    Biomarkers level Pre-op

    Time frame: Pre-operative, H0 right after induction of general anesthesia

  25. Biomarkers level H24

    Biomarkers level H24

    Time frame: Day 1 24 hours

  26. Biomarkers level H48

    Biomarkers level H48

    Time frame: Day 2 48 hours

  27. Brief Pain inventory (3M) Questionnaire (validated and published questionnaire)

    Brief Pain inventory (3M)

    Time frame: 3 months

07

Study locations

1 site
  • Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal
    Montreal East, Quebec H1T2M4, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03422783
Lead sponsor
Ciusss de L'Est de l'Île de Montréal
Responsible party
Philippe Richebe (Director of Research in the Department of Anesthesiology, Ciusss de L'Est de l'Île de Montréal) — Principal investigator
First posted
Feb 6, 2018
Start date
Jan 15, 2018
Primary completion
Mar 7, 2024
Completion
Mar 7, 2024
Last update
Jul 17, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Biomarkers

Start the discussion